Skip to content

Role Of Homoeopathy In Treatment Of Primary Dysmenorrhea

Usefulness of Individualized Homoeopathic Medicine Along With Miasmatic Approach And Lifestyle Management In Primary Dysmenorrhea - Randomized controlled Study. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054162
Enrollment
72
Registered
2023-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Sponsors

Bakson Homeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient between 10 years to 19 years for the adolescent age group 2 Pain occurring since menarche as well as pre menopause 3 Clinical features of primary dysmenorrhea must be present during most menstrual cycles which includes pain arising on the first day of menses spasmodic pain and confined to the lower abdomen This pain may radiate to the back and middle aspect of the thigh 4 Those having mild or moderate dysmenorrhea 5 Patients with a regular menstrual cycle of 21-35 days

Exclusion criteria

Exclusion criteria: 1 patients with regular menstrual cycles of more than 35 days or less than 21 days 2 patients taking any other treatment for any other complaints 3 patient with any other pelvic disease leading to secondary dysmenorrhea sech as fibroid PCOD endometriosis Pelvic Inflammatory Diseases 4 Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Expected reduction in VRS scaleTimepoint: VRS scale will be used at baseline, 4 weeks, 8 weeks, 12 weeks etc

Secondary

MeasureTime frame
Expected reduction in WaLLID ScoreTimepoint: WaLLID score will be done at baseline, 4 weeks, 8 weeks, 12 weeks etc

Countries

India

Contacts

Public ContactAnuroopam Swami

Bakson Homoeopathic Medical College Greater Noida

dr.anjusingh28@gmail.com9026145849

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026